...
首页> 外文期刊>Tobacco control >Heated tobacco products likely appeal to adolescents and young adults
【24h】

Heated tobacco products likely appeal to adolescents and young adults

机译:加热的烟草制品可能对青少年和年轻人有吸引力

获取原文
获取原文并翻译 | 示例
           

摘要

Background Beginning in the 1960s in the USA and globally since 1998, tobacco companies have beenaggressively promoting heated tobacco products (HTP). In 2016, Philip Morris International (PMI) applied to the US Food and Drug Administration (FDA) seeking authorisation to market their IQOS HTP system and flavoured 'HeatSticks' in the USA as a modified-risk tobacco product (MRTP).Methods We systematically evaluated the publicly available data PMI submitted to FDA in its MRTP application to determine whether PMI's IQOS product meets the US Tobacco Control Act's standard for MRTP claims. We examined whether PMI provided sufficient data showing tobacco users will not initiate with IQOS, that youth will not misperceive the MRTP-related claims being made concerning IQOS, and how youth perceive health risks associated with IQOS.Results PMI's own studies failed to provide evidence that youth, including non-users and former users, will not find IQOS appealing, will not initiate use of IQOS and will not perceive these products as risk-free. Further, PMI did not refer to independent studies conducted among adolescents which could influence their conclusions. Finally, their studies suffered from design and implementation flaws and cannot be relied on to support the proffered claims.Conclusion PMI's own data and available evidence from scientific studies conducted independent of the tobacco industry regarding how novel tobacco products are currently being marketed suggest that introduction of IQOS will result in adolescent and young adult non-users initiating tobacco use with IQOS and could also increase poly-use of IQOS along with other tobacco products.
机译:背景从1960年代开始,在美国以及1998年以来的全球范围内,烟草公司一直在积极地推广加热烟草制品(HTP)。 2016年,菲利普·莫里斯国际公司(PMI)向美国食品药品监督管理局(FDA)申请获得授权,以销售其IQOS HTP系统并在美国将风味调味品``HeatSticks''作为改良风险烟草产品(MRTP)。评估了PMI在MRTP申请中提交给FDA的公开数据,以确定PMI的IQOS产品是否符合《美国烟草控制法》针对MRTP声明的标准。我们检查了PMI是否提供了足够的数据来表明烟草使用者不会开始使用IQOS,年轻人不会误解有关IQOS的MRTP相关声明,以及年轻人如何看待与IQOS相关的健康风险。结果PMI自己的研究未能提供证据证明青少年,包括非用户和以前的用户,不会发现IQOS具有吸引力,不会开始使用IQOS,也不会认为这些产品没有风险。此外,PMI并未提及可能影响其结论的青少年间的独立研究。最后,他们的研究存在设计和实现方面的缺陷,不能依靠它们来支持提出的主张。结论PMI自身的数据以及与烟草业无关的,有关当前如何销售新型烟草产品的科学研究的可用证据表明,引入IQOS将导致青少年和年轻人非使用者开始使用IQOS进行烟草使用,并且还可能增加IQOS与其他烟草产品的多用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号